These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8038480)

  • 1. Medicaid policies for HIV-related drug therapies: perspectives of the state affiliates of the American Pharmaceutical Association.
    Buchanan RJ; Smith SR
    Ann Pharmacother; 1994 Apr; 28(4):528-35. PubMed ID: 8038480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicaid policies for HIV-related prescription drugs.
    Buchanan RJ; Smith SR
    Health Care Financ Rev; 1994; 15(3):43-61. PubMed ID: 10137797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid payment policies for nursing home care: a national survey.
    Buchanan RJ; Madel RP; Persons D
    Health Care Financ Rev; 1991; 13(1):55-72. PubMed ID: 10114935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
    Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
    N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interest groups and state Medicaid drug programs.
    Pracht EE; Moore WJ
    J Health Polit Policy Law; 2003 Feb; 28(1):9-39. PubMed ID: 12705416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State Medicaid and private payer reimbursement for telemedicine: An overview.
    Brown NA
    J Telemed Telecare; 2006; 12 Suppl 2():S32-9. PubMed ID: 16989672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring fiscal integrity to medicaid financing?
    Coughlin TA; Zuckerman S; McFeeters J
    Health Aff (Millwood); 2007; 26(5):1469-80. PubMed ID: 17848459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicaid program; limitations on aggregate payments to disproportionate share hospitals: fiscal year 1993--HCFA. Notice.
    Fed Regist; 1992 Nov; 57(227):55261-5. PubMed ID: 10122881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
    Academy of Managed Care Pharmacy
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicaid reimbursement for alternative therapies.
    Steyer TE; Freed GL; Lantz PM
    Altern Ther Health Med; 2002; 8(6):84-8. PubMed ID: 12440844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State Medicaid pharmacy payments and their relation to estimated costs.
    Adams EK; Kreling DH; Gondek K
    Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-based payment for HIV/AIDS in Medicaid managed care programs.
    Conviser R; Gamliel S; Honberg L
    Health Care Financ Rev; 1998; 19(3):63-82. PubMed ID: 10345414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicaid managed care reimbursement for HIV and its implications for access to care.
    Conviser R; Murray M; Lau D
    Am J Manag Care; 2000 Sep; 6(9):990-9. PubMed ID: 11184069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid program; limitations on aggregate payments to disproportionate share hospitals: FFY 1995--HCFA. Notice.
    Fed Regist; 1995 Jan; 60(9):3250-3. PubMed ID: 10139996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid policies for AIDS-related hospital care.
    Buchanan RJ; Kircher FG
    Health Care Financ Rev; 1994; 15(4):33-41. PubMed ID: 10138485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid program; limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1994--HCFA. Notice.
    Fed Regist; 1994 Feb; 59(21):4717-20. PubMed ID: 10133068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2004 Feb; 350(6):608-13. PubMed ID: 14762190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.